Diane Helentjaris, MD, Past AMWA President, represented AMWA at a briefing on Cord Blood in Washington DC recently.
Newborn stem cells and cord blood, banked through both private and public entities, is an important women’s health issue and this tool is currently used in transplant medicine to replace affected cells and treat blood cancers and solid tumors, immune disorders, metabolic disorders and genetic diseases. Research is now looking into its use to restore new cells for such diseases and conditions as autism, brain injury, diabetes and spinal cord injuries. The Stem Cell Act is up for reauthorization this year.
Online CME education is available here.